IFNA1 and Cirrhosis: As such, the recommendation is that all patients with compensated cirrhosis (treatment-naïve and experienced) should be treated with boceprevir + PEG/IFN-RBV for 44 weeks following an initial lead-in phase of 4 weeks of PEG-IFN/RBV therapy [6].